The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1338
ISSUE1338
May 17, 2010
Another Once-Daily Formulation of Tramadol (Ryzolt)
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
Another Once-Daily Formulation of Tramadol (Ryzolt)
May 17, 2010 (Issue: 1338)
The FDA has approved tramadol hydrochloride extended-release (Ryzolt – Purdue) for treatment of
moderate to moderately severe chronic pain in adults. Tramadol is already available in another extended-release formulation (Ultram ER) and in...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.